World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

New player emerges in 23andMe bankruptcy An Indian drug company has big plans for the East Bay An Indian drug company has big ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.

Ligand Pharmaceuticals offers investors exposure to dozens of therapies, reducing risk and increasing upside potential. See ...

Liminatus Pharma is a preclinical oncology company focused on a CD47 antibody. Check out why I see little reason for ...

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic syndromes.